Related Experiment Video
Updated: Sep 9, 2025
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
13.2K
Then and Now: Medical Therapy for Glaucoma
Eydie Miller-Ellis1, Gloria P Fleming2
1Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Ophthalmology. Glaucoma
|September 4, 2025
Summary
Glaucoma medical therapy has evolved significantly over 40 years, moving from limited options to patient-centered treatments focusing on efficacy and quality of life. Innovations in drug delivery and formulation have improved compliance and reduced side effects for glaucoma patients.
Area of Science:
- Ophthalmology
- Pharmacology
- Medical Innovation
Background:
- Glaucoma treatment has evolved over four decades since the American Glaucoma Society's founding in 1985.
- Early treatments were limited and poorly tolerated, leading to nonadherence and disease burden.
- Advances in understanding side effects and patient quality of life have driven therapeutic changes.
Purpose of the Study:
- To review the evolution of medical therapy for glaucoma over the past 40 years.
- To highlight key developments in glaucoma treatment strategies.
- To emphasize the shift towards patient-centered care prioritizing efficacy and quality of life.
Main Methods:
- Review of pharmacological advancements and drug delivery innovations in glaucoma management.
- Analysis of the transition from systemic to topical formulations.
- Examination of the development of once-daily dosing and sustained-release delivery models.
- Consideration of the impact of preservative-free formulations on ocular surface health.
Main Results:
- Significant transformation from limited, poorly tolerated options to sophisticated, patient-centered glaucoma therapies.
- Mitigation of systemic side effects through topical formulations.
- Improved patient compliance via once-daily regimens and sustained-release technologies.
- Enhanced ocular surface health with preservative-free formulations.
Conclusions:
- The four-decade evolution in glaucoma medical management showcases scientific innovation's power to preserve vision and enhance patient quality of life.
- Medical management remains a cornerstone of glaucoma treatment algorithms, even with evolving surgical interventions.
- Patient-centered approaches prioritizing efficacy, convenience, and reduced side effects are paramount in modern glaucoma therapy.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
554
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
554
01:28Angle Closure Glaucoma: Treatment
665
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
665
01:25Glaucoma: Overview
740
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
740
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
866
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
866
01:28Drug Therapy
96
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
96
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.5K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.5K